MedTrace Logo

Impact of HPV Vaccine On The Prevalence Of HPV In Norway

NCT02934724 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 315

Last updated 2020-12-14

No results posted yet for this study

Summary

The overall aim of the study is to assess the effect of school-based Human Papillomavirus (HPV) vaccination by comparing type-specific HPV prevalence between vaccinated and non-vaccinated women born in 1997. Women born in 1997, residence to Norway in 2009 (the year of vaccine initiation of the 1997-cohort) are invited to participate in the study.

Conditions

Interventions

PROCEDURE

Self sample from vagina

Self sample using The Rover's Evalyn Brush

PROCEDURE

Self sample from the oral cavity

Self sample using COPAN FloqSwab

OTHER

Questionnaire

Questionnaire about vaccination status and sexual behaviour

Sponsors & Collaborators

  • University Hospital, Akershus

    collaborator OTHER

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Espen Enerly, Dr Scient · Oslo University Hospital

  • Giske Ursin, Dr.Med · Oslo University Hospital

Eligibility

Min Age
18 Years
Max Age
20 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2017-02-28
Completion
2017-02-28

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02934724 on ClinicalTrials.gov